“Treating [plant medicine] as dangerous or criminal isn’t just scientifically unsupported—it’s a separation from something that has always belonged to us.”
Legislators advance two different psychedelic therapy bills, will consider landmark programs for ibogaine and psilocybin
Newly-filed federal measure would require Department of Veterans Affairs to establish “innovative therapies centers of excellence”
Legislative proposals present differing pilot programs, sparking debate among experts and advocates on the future of psychedelics
CJ LoConte: “For the first time, I was able to let go of the blame and guilt and shame that I kept bottled up from the military.”
A “quirky brand of integration wisdom” with Tam Integration founder Daniel Shankin
The legislation is unique from other measures in consideration for its broad scope, including ibogaine and MDMA
A Q+A with Boston Psychedelic Society Founder Dr. Christina O’Flaherty
“I felt obligated to personally do something to help push decriminalization, and to tell people that psychedelics are nothing to be afraid of.”
An interview with Entheogen Melanin Collective Co-Founder Julian Fox
